Cytosorbents

company

About

Cytosorbents develops therapeutic devices used in purifying blood to treat life-threatening diseases.

  • 101 - 250

Details

Last Funding Type
Grant
Last Funding Money Raised
$719K
Industries
Biotechnology,Pharmaceutical,Therapeutics
Founded date
Jan 1, 1997
Number Of Employee
101 - 250
Operating Status
Active

CytoSorbents Corporation is a publicly-traded, critical care focused therapeutic device company using blood purification to treat life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Each polymer bead contains millions of pores and channels that can be modified to remove substances as small as drugs, to substances as large as antibodies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$719K
Cytosorbents has raised a total of $719K in funding over 2 rounds. Their latest funding was raised on Aug 14, 2017 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 14, 2017 Grant $719K 1 U.S. Army Medical Research & Development Command Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Cytosorbents is funded by 1 investors. U.S. Army Medical Research & Development Command are the most recent investors.
Investor Name Lead Investor Funding Round
U.S. Army Medical Research & Development Command Yes Grant